There are 2949 resources available
Q&A and live discussion
Presenter: Rosa Giuliani
Session: Proffered Paper - Public Policy
Resources:
Webcast
Invited Discussant 1582O, 1583O and 1584O
Presenter: Christophe Le Tourneau
Session: Proffered Paper - Public Policy
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Rosa Giuliani
Session: Proffered Paper - Public Policy
Resources:
Webcast
Invited Discussant LBA51, LBA52 and LBA53
Presenter: Roy Herbst
Session: Proffered Paper - NSCLC metastatic 2
Resources:
Slides
Webcast
Q&A live discussion
Presenter: Roy S. Herbst
Session: Proffered Paper - NSCLC metastatic 2
Resources:
Webcast
Invited Discussant LBA54 and LBA55
Presenter: Adrian Sacher
Session: Proffered Paper - NSCLC metastatic 2
Resources:
Slides
Webcast
Q&A live discussion
Presenter: Roy S. Herbst
Session: Proffered Paper - NSCLC metastatic 2
Resources:
Webcast
Q&A and live discussion
Presenter: Silke Gillessen
Session: Proffered Paper - GU, prostate
Resources:
Webcast
609O - Results from a phase I study of AMG 160, a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE®) immune therapy for metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Ben Tran
Session: Proffered Paper - GU, prostate
Resources:
Abstract
Slides
Webcast
611O - Abiraterone acetate plus prednisolone for hormone-naïve prostate cancer (PCa): Long-term results from metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476)
Presenter: Nicholas James
Session: Proffered Paper - GU, prostate
Resources:
Abstract
Slides
Webcast